A systematic review of phenibut withdrawal focusing on complications, therapeutic approaches, and single substance versus polysubstance withdrawal

References

• Graves JM, Dilley J, Kubsad S, et al. Notes from the field: phenibut exposures reported to poison centers – United States, 2009–2019. MMWR Morb Mortal Wkly Rep. 2020;69(35):1227–1228. doi:10.15585/mmwr.mm6935a5.
   PubMed Web of Science ®Google Scholar
• Brunner E, Levy R. Case report of physiologic phenibut dependence treated with a phenobarbital taper in a patient being treated with buprenorphine. J Addict Med. 2017;11(3):239–240. doi:10.1097/ADM.0000000000000303.
   Web of Science ®Google Scholar
• Kupats E, Vrublevska J, Zvejniece B, et al. Safety and tolerability of the anxiolytic and nootropic drug phenibut: a systematic review of clinical trials and case reports. Pharmacopsychiatry. 2020;53(5):201–208. doi:10.1055/a-1151-5017.
   Google Scholar
• Gilbert D, Wolters W, Rayapati A, et al. Prolonged withdrawal associated with phenibut, a GABA analogue. ACAAM 2020 Annual Meeting. 2023 [cited 2023 May 5]. Abstracts-of-the-ACAAM-2020-Annual Meeting.pdf (memberclicks.net)
   Google Scholar
• Magsalin RM, Khan AY. Withdrawal symptoms after internet purchase of phenibut (β-phenyl-γ-aminobutyric acid HCl). J Clin Psychopharmacol. 2010;30(5):648–649. doi:10.1097/JCP.0b013e3181f057c8.
   PubMed Web of Science ®Google Scholar
• Hardman MI, Sprung J, Weingarten TN. Acute phenibut withdrawal: a comprehensive literature review and illustrative case report. Bosn J Basic Med Sci. 2019;19(2):125–129. doi:10.17305/bjbms.2018.4008.
   Web of Science ®Google Scholar
• Sethi R, Ravishankar DA, Nagireddy R. Phenibut dependence and withdrawal. Prim Care Companion CNS Disord. 2021;23(1):19l02457. doi:10.4088/PCC.19l02457.
   Google Scholar
• VanDreese B, Holland A, Murray A. Chronic phenibut use: symptoms, severe withdrawal, and recovery. WMJ. 2022;121(1):E1–E4.
   Google Scholar
• Joshi YB, Friend SF, Jimenez B, et al. Dissociative intoxication and prolonged withdrawal associated with phenibut: a case report. J Clin Psychopharmacol. 2017;37(4):478–480. doi:10.1097/JCP.0000000000000731.
   Web of Science ®Google Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473. doi:10.7326/M18-0850.
   PubMed Web of Science ®Google Scholar
• The Joanna Briggs Institute. Checklist for case reports; 2017. https://jbi.global/sites/default/files/2019-05/JBI_Critical_AppraisalChecklist_for_Case_Reports2017_0.pdf. Accessed 5/20 2023.
   Google Scholar
• Srihari P, Ly BT. Phenibut withdrawal requiring large doses of baclofen and phenobarbital. Clin Toxicol. 2020;58(11):1224.
   Web of Science ®Google Scholar
• Pena F, Manzar S, Dominguez MG. Phenibut withdrawal management in a neonate. Pediatr Neonatol. 2022;63(6):661–662. doi:10.1016/j.pedneo.2022.02.007.
   Web of Science ®Google Scholar
• Morris M, Espinosa J, Lucerna A, et al. A case of phenibut withdrawal and treatment with baclofen. World J Emerg Med. 2023;14(4):338–340. doi:10.5847/wjem.j.1920-8642.2023.059.
   Web of Science ®Google Scholar
• Samokhvalov AV, Paton-Gay CL, Balchand K, et al. Phenibut dependence. BMJ Case Rep. 2013;2013(1):bcr2012008381. bcr2012008381. doi:10.1136/bcr-2012-008381.
   Google Scholar
• Patt A, Fox H, Wells L, et al. Seizure occurring during baclofen monotherapy for phenibut withdrawal. Clin Neuropharmacol. 2023;46(2):79–81. doi:10.1097/WNF.0000000000000542.
   Web of Science ®Google Scholar
• Odujebe OA, Hoffman RS, Nelson LS. Phenibut withdrawal – a novel “nutritional supplement. Clin Toxicol. 2008;46(7):605.
   Web of Science ®Google Scholar
• Thalambedu N, Roomi S. Phenibut poisoning. Chest. 2020;158(4):A803. doi:10.1016/j.chest.2020.08.748.
   Web of Science ®Google Scholar
• Coenen NCB, Dijkstra BAG, Batalla A, et al. Detoxification of a patient with comorbid dependence on phenibut and benzodiazepines by tapering with baclofen: case report. J Clin Psychopharmacol. 2019;39(5):511–514. doi:10.1097/JCP.0000000000001104.
   Web of Science ®Google Scholar
• Goldfine C, Lai J. Phenibut withdrawal syndrome successfully treated using oral baclofen. Clin Toxicol. 2019;57(10):1005–1006.
   Web of Science ®Google Scholar
• Keenan M, Hodgman M. Phenibut withdrawal treated with a baclofen taper. Clin Toxicol. 2019;57(10):901–902.
   Web of Science ®Google Scholar
• Mash JE, Leo RJ. Phenibut: a novel nootropic with abuse potential. Prim Care Companion CNS Disord. 2020;22(4):19l02587. doi:10.4088/PCC.19l02587.
   Google Scholar
• McCabe DJ, Bangh SA, Arens AM, et al. Phenibut exposures and clinical effects reported to a regional poison center. Am J Emerg Med. 2019;37(11):2066–2071. doi:10.1016/j.ajem.2019.02.044.
   PubMed Web of Science ®Google Scholar
• Wainblat E, Weleff J, Anand A. Management of phenibut use disorder and withdrawal in a geriatric patient. Am J Geriatr Psychiatry. 2023;31(1):67–74. doi:10.1016/j.jagp.2022.09.008.
   Web of Science ®Google Scholar
• Ahuja T, Mgbako O, Katzman C, et al. Phenibut (β-phenyl-γ-aminobutyric acid) dependence and management of withdrawal: emerging nootropics of abuse. Case Rep Psychiatry. 2018;2018:9864285. doi:10.1155/2018/9864285.
   PubMedGoogle Scholar
• McDermott S, Johnson BE, Balasanova AA. Phenibut and bromazolam use disorders requiring hospitalization for medically supervised withdrawal. Prim Care Companion CNS Disord. 2022;24(4):21cr03119. doi:10.4088/PCC.21cr03119.
   Google Scholar
• Rod W, Kudryk A, Brunetti L, et al. Phenibut withdrawal management in the setting of concomitant kratom and alcohol dependence. Crit Care Med. 2018;46(1):451–451. doi:10.1097/01.ccm.0000528942.37373.7a.
   Web of Science ®Google Scholar
• Westover R, Shao S, Micciche AF, et al. Severe phenibut withdrawal requiring mechanical ventilation, high-dose phenobarbital, and baclofen for symptom control. J Med Toxicol. 2020;16:129–130.
   Google Scholar
• Zheng KH, Khan A, Espiridion ED. Phenibut addiction in a patient with substance use disorder. Cureus. 2019;11(7):e5230. doi:10.7759/cureus.5230.
   Web of Science ®Google Scholar
• Owen DR, Wood DM, Archer JRH, et al. Phenibut (4-amino-3-phenyl-butyric acid): availability, prevalence of use, desired effects and acute toxicity. Drug Alcohol Rev. 2016;35(5):591–596. doi:10.1111/dar.12356.
   PubMed Web of Science ®Google Scholar
• Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med. 2014;371(22):2109–2113. doi:10.1056/NEJMra1407298.
   PubMed Web of Science ®Google Scholar
• Dambrova M, Zvejniece L, Liepinsh E, et al. Comparative pharmacological activity of optical isomers of phenibut. Eur J Pharmacol. 2008;583(1):128–134. doi:10.1016/j.ejphar.2008.01.015.
   PubMed Web of Science ®Google Scholar